0406-8894-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · SpecGx LLC
What is the status for 0406-8894-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · SpecGx LLC?
For 0406-8894-01, generic name is Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet; manufacturer is SpecGx LLC; status is Current; availability now is Limited Availability; fda note is Estimated recovery: TBD, recorded from its source on 2026-11-04.
"initial_posting_date": "10/12/2022", "package_ndc": "0406-8894-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 0406-8894-01 verified
- Generic name
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet verified
- Manufacturer
- SpecGx LLC verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Estimated recovery: TBD verified
- Initial posting date
- 10/12/2022 verified
- Last update date
- 08/20/2026 verified
- Days in shortage
- 1484 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Tablet verified
- Therapeutic category
- Psychiatry verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)", "company_name": "SpecGx LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000